DAVOS WATCH: ‘Where Biology Meets Choice’

Credit: World Economic Forum

‘Advances in DNA and RNA research are transforming medicine, preventing disease, enhancing therapies and extending human health. Yet as the power to alter genes grows, so do questions of equity, consent and what it means to be human.

‘As the boundaries between therapy and enhancement blur, how do we decide what should and shouldn’t be edited?

Speakers:

• Daniel de Boer — Chief Executive Officer, ProQR Therapeutics
• Natalie Edwards — Global Shaper, Santiago Hub
• Victor Ambros — Silverman Chair in Natural Sciences and Professor of Molecular Medicine, University of Massachusetts Medical School
• Irene Tracey — Vice-Chancellor, University of Oxford
• Eva McLellan — Vice-President, Global Commercialization Strategy, Cardio-Renal-Metabolic, Roche